BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7531659)

  • 1. [Immunocytochemical detection of tumor cells in bone marrow as a prognostic factor in breast carcinoma].
    Merkle E; Bähr J; Henke A; Bühner M; Martus P
    Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):662-9. PubMed ID: 7531659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prognostic significance of tumor cell detection in bone marrow of patients with breast cancer].
    Diel IJ; Kaufmann M; Costa SD; Kaul S; Krempien B; Goerner R; Bastert G
    Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):923-8. PubMed ID: 1707840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.
    Janni W; Rack B; Schindlbeck C; Strobl B; Rjosk D; Braun S; Sommer H; Pantel K; Gerber B; Friese K
    Cancer; 2005 Mar; 103(5):884-91. PubMed ID: 15666325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
    Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
    J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunocytochemical detection and prognostic significance of epithelial tumor cells in bone marrow of patients with pancreatic carcinoma].
    Thorban S; Roder JD; Pantel K; Siewert JR
    Zentralbl Chir; 1996; 121(6):487-9; discussion 490-2. PubMed ID: 8767337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.
    Wiedswang G; Borgen E; Kåresen R; Kvalheim G; Nesland JM; Qvist H; Schlichting E; Sauer T; Janbu J; Harbitz T; Naume B
    J Clin Oncol; 2003 Sep; 21(18):3469-78. PubMed ID: 12972522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of tumor cells in bone marrow: a deciding aid for adjuvant therapy in node negative patients with breast cancer. Concept for a multicenter study and results of the pilot phase].
    Funke I; Fries S; Jauch KW
    Chirurg; 1991 Nov; 62(11):805-9. PubMed ID: 1769261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
    Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
    Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
    Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
    Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolated tumor cells in bone marrow predicts reduced survival in lymph node-negative non-small-cell lung cancer].
    Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
    Pneumologie; 2000 Aug; 54(8):355-60. PubMed ID: 11008478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
    Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
    J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus.
    Janni W; Hepp F; Strobl B; Rack B; Rjosk D; Kentenich C; Schindlbeck C; Hantschmann P; Pantel K; Sommer H; Braun S
    Cancer; 2003 Jan; 97(2):405-11. PubMed ID: 12518364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
    Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
    J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.